Lin Liang, Kightlinger Weston, Prabhu Sunaina Kiran, Hockenberry Adam J, Li Chao, Wang Lai-Xi, Jewett Michael C, Mrksich Milan
Department of Biomedical Engineering, Center for Synthetic Biology, Department of Chemical and Biological Engineering, Interdisciplinary Biological Sciences Program, and Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States.
Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.
ACS Cent Sci. 2020 Feb 26;6(2):144-154. doi: 10.1021/acscentsci.9b00021. Epub 2020 Feb 19.
Protein glycosylation is a common post-translational modification that influences the functions and properties of proteins. Despite advances in methods to produce defined glycoproteins by chemoenzymatic elaboration of monosaccharides, the understanding and engineering of glycoproteins remain challenging, in part, due to the difficulty of site-specifically controlling glycosylation at each of several positions within a protein. Here, we address this limitation by discovering and exploiting the unique, conditionally orthogonal peptide acceptor specificities of -glycosyltransferases (NGTs). We used cell-free protein synthesis and mass spectrometry of self-assembled monolayers to rapidly screen 41 putative NGTs and rigorously characterize the unique acceptor sequence preferences of four NGT variants using 1254 acceptor peptides and 8306 reaction conditions. We then used the optimized NGT-acceptor sequence pairs to sequentially install monosaccharides at four sites within one target protein. This strategy to site-specifically control the installation of -linked monosaccharides for elaboration to a variety of functional -glycans overcomes a major limitation in synthesizing defined glycoproteins for research and therapeutic applications.
蛋白质糖基化是一种常见的翻译后修饰,它会影响蛋白质的功能和特性。尽管通过单糖的化学酶法合成来制备特定糖蛋白的方法取得了进展,但糖蛋白的理解和工程改造仍然具有挑战性,部分原因在于难以在蛋白质内的多个位置上对糖基化进行位点特异性控制。在此,我们通过发现和利用N-糖基转移酶(NGTs)独特的、条件性正交的肽受体特异性来解决这一限制。我们使用无细胞蛋白质合成和自组装单层膜的质谱分析,快速筛选了41种假定的NGTs,并使用1254种受体肽和8306种反应条件,严格表征了四种NGT变体独特的受体序列偏好。然后,我们使用优化后的NGT-受体序列对,在一个目标蛋白的四个位点上依次安装单糖。这种位点特异性控制β-连接单糖安装以构建多种功能性β-聚糖的策略,克服了在合成用于研究和治疗应用的特定糖蛋白方面的一个主要限制。